Indications and uses
Indication and Usage: Spray onto areas exposed to UV rays from about 20-30cm aways. (Use before or after makeup.)
Indication and Usage: Spray onto areas exposed to UV rays from about 20-30cm aways. (Use before or after makeup.)
Dosage and Administration: 2-3 time spry onto the areas that exposed to UV rays, and tap on applied skin for better aborption.
Active Ingredients: Ethylhexyl Methoxycinnamate 7%, Ethylhexyl Salicylate 4%
Inactive Ingredients:
Water, Butylene Glycol, Caprylic/Capric Triglyceride, Phenylbenzimidazole Sulfonic Acid, Disiloxane, Diethylamino Hydroxybenzoyl Hexyl Benzoate, Ceteareth-6 Olivate, Niacinamide, Bis-Ethylhexyloxyphenol Methoxyphenyl Triazine, Tromethamine, Dimethicone, Tocopheryl Acetate, Benzyl Alcohol, Microcrystalline Cellulose, Fragrance, Portulaca Oleracea Extract, Phenoxyethanol, Sodium Benzoate, Disodium EDTA, Potassium Sorbate, Glycerin, Cetearyl Olivate, Sorbitan Olivate, Adenosine, Cellulose Gum, Alpinia Officinarum Root Extract, Lactobacillus/Nelumbo Nucifera Seed Ferment Filtrate, Citrullus Lanatus (Watermelon) Fruit Extract, Terminalia Chebula Fruit Extract, Abies Koreana Leaf Extract, Aloe Barbadensis Leaf Juice
Purpose: UVA/UVB Protection
Warnings:
1. If following symptoms occur, stop use and consult a doctor: red spots, swelling, itcihng, irritation, or symtoms on applied skin under direct sunlight.
2. Do not use on scarred skin, or if you have dermatitis or eczema
3. Keep the cap close on its product
4. Keep away from direct sunlight or heat.
Keep out of reach of children:
Keep out of reach of babies and children
Indication and Usage:
Spray onto areas exposed to UV rays from about 20-30cm aways. (Use before or after makeup.)
Dosage and Administration:
2-3 time spry onto the areas that exposed to UV rays, and tap on applied skin for better aborption.
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 57718-030-01 | 2019-11-27 | C162847 | 48780-1 | 9855e2a2-4707-60a7-e053-dbdaa90a05bd | 24d24776-0f5e-4218-b29f-e8461528a6c3 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57718-030-01 | UV BOUNCE MIST | 50 mL in 1 CARTON | SPRAY | 50 | 2 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 2 | |
| OCTISALATE | ACTIVE INGREDIENT | 4X49Y0596W | 2 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 2 | |
| OCTISALATE | ACTIVE MOIETY | 4X49Y0596W | 2 | |
| Butylene Glycol | INACTIVE INGREDIENT | 3XUS85K0RA | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 57718-030 | 57718-030-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| OCTINOXATE | 4Y5P7MUD51 | ACTIB |
| OCTISALATE | 4X49Y0596W | ACTIB |
| Water | 059QF0KO0R | IACT |
| Butylene Glycol | 3XUS85K0RA | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Butylene Glycol | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| Butylene Glycol | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TRANSDERMAL | 8.12 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 8cc727f5-ec75-48ae-af9e-394216f98f23 | 24d24776-0f5e-4218-b29f-e8461528a6c3 | 2014-04-17 | Warnings | 8cc727f5-ec75-48ae-af9e-394216f98f23 24d24776-0f5e-4218-b29f-e8461528a6c3 |
Adverse event summaries are temporarily unavailable. Other product information remains available.